Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03921801
Other study ID # LS_Plantarflex
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 13, 2023
Est. completion date February 28, 2024

Study information

Verified date March 2024
Source University of Eastern Finland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates the role of calf muscle function in gait performance, balance and knee joint loading. Previous studies have linked age-related loss of calf muscle function with impairments in gait performance and balance, and increased loading of the areas of the knee joint that are susceptible to the development of osteoarthritis. In this study, an exercise intervention targeting structural and neural aspects of impaired calf muscle function with ageing is utilized. The intervention lasts 8 weeks and includes either biofeedback training using electromyography to alter muscle activation patterns or a combination of biofeedback training and strength training for the calf muscle to modify calf function during walking. The study will test whether the intervention improves walking speed, reduces the metabolic cost of walking, improves standing balance and reduces knee joint loading.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date February 28, 2024
Est. primary completion date February 28, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years to 75 Years
Eligibility Inclusion Criteria: - age between 65 and 75 Exclusion Criteria: - dependent living status - not able to walk without an assistive device or for 30 min without stopping - diagnosed neurological disease or joint disorder and pain during walking - surgery on lower extremities - current musculoskeletal injury - previous cardiovascular event or symptoms during exercise (acute ECG change, coronary disease, symptomatic arrhythmia, symptomatic coronary stenosis, heart failure, myocarditis, pericarditis, pulmonary embolism, pulmonary infarct, artery bulge or rupture risk) - body mass index <18 or >35 kg/m2 - contraindications for magnetic resonance imaging - Mini Mental State Examination score of 23 points and lower

Study Design


Intervention

Other:
Gait retraining
Gait retraining using real-time electromyography biofeedback performed once per week for eight weeks. During the gait retraining session the participant is walking on a treadmill while receiving information on calf muscle activation. A single session includes five bouts of walking each lasting for 5 minutes. During the first bout, the participant is receiving feedback (visual and auditive) on soleus muscle activation with the aim to increase it by 20% from their normal walking. During the second bout, the participant is receiving feedback (visual and auditive) on medial gastrocnemius muscle activation with the aim to decrease it by 20% from their normal walking. During the last three bouts, the participant is receiving feedback (visual and auditive) on the soleus to medial gastrocnemius muscle activation ratio with the aim to increase it by 20% from their normal walking. If hitting the target, the aim is increased by 5% for the subsequent bout.
Gait retraining + strength training
Gait retraining using real-time electromyography biofeedback performed once per week and home-based calf muscle strength training performed three times per week for eight weeks. The gait retraining is identical to the one intervention described for the intervention group "Gait retraining". The strength training is performed three times per week except for the first week in which it is performed two times. The session contained a warm-up (3x10 repetitions of two-legged heel raises) and maximal isometric calf muscle contractions. The maximal contractions are performed using a custom device with the ankle in dorsiflexion and the knee flexed by 100-120 degrees. Three sets of 10 repetitions (3-second contraction and 3-second rest) are performed with both legs and with maximal effort and 1-minute rest between the sets.

Locations

Country Name City State
Finland University of Eastern Finland Kuopio North Savo

Sponsors (1)

Lead Sponsor Collaborator
University of Eastern Finland

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Other Change from baseline in triceps surae fascicle lengths Soleus and gastrocnemius muscle fascicle length assessed using ultrasound imaging. within 1 weeks after intervention
Other Change from baseline in triceps surae fascicle pennation angle Soleus and gastrocnemius muscle pennation angle assessed using ultrasound imaging. within 1 weeks after intervention
Other Change from baseline in triceps surae muscle volume Soleus and gastrocnemius muscle volume estimated with combination of ultrasound and magnetic resonance imaging. within 1 weeks after intervention
Other Change from baseline in Achilles tendon cross-sectional area Achilles tendon cross-sectional area assessed using magnetic resonance imaging. within 1 weeks after intervention
Other Change from baseline in dynamics balance control Perturbed standing balance test with measurement of center of pressure trajectory within 1 weeks after intervention
Other Change from baseline in triceps surae muscle activity in response to balance perturbation Perturbed standing balance test with measurement of triceps surae muscle activities. within 1 weeks after intervention
Primary Change from baseline in knee joint loading Change in tibiofemoral compressive loading during walking estimated using musculoskeletal modeling and simulation. Loading is calculated separately for medial and lateral compartments of the tibiofemoral joint. within 1 weeks after intervention
Secondary Change from baseline in energy cost of walking Assessed using indirect calorimetry. within 1 weeks after intervention
Secondary Change from baseline in standing balance Sway during standing measured using a force plate with eyes open and closed within 1 weeks after intervention
Secondary Change from baseline in Achilles tendon stiffness Achilles tendon stiffness evaluated using combination of ultrasonography, motion analysis and force measurements. within 1 weeks after intervention
Secondary Change from baseline in gait kinematics Time series of lower limb joint angles during walking stride assessed using motion capture system and inverse kinematics. within 1 weeks after intervention
Secondary Change from baseline in joint moments during walking Time series of lower limb joint moments during walking stride assessed using inverse dynamics based on motion capture system and instrumented treadmill data. within 1 weeks after intervention
Secondary Change from baseline in joint powers during walking Time series of lower limb joint powers during walking stride assessed using inverse dynamics based on motion capture system and instrumented treadmill data. within 1 weeks after intervention
Secondary Change from baseline in distribution of joint work during walking Distribution of total positive lower limb work between the joints during walking assessed using inverse dynamics based on motion capture system and instrumented treadmill data. within 1 weeks after intervention
Secondary Change from baseline in muscle-tendon function during walking Muscle fascicle kinematics measured using dynamics ultrasonography during walking. within 1 weeks after intervention
Secondary Change from baseline in soleus to gastrocnemius muscle activation ratio Relative activation of soleus to medial gastrocnemius measured using electromyography. within 1 weeks after intervention
Secondary Change from baseline in walking speed Preferred and maximal walking speed. within 1 weeks after intervention
Secondary Change from baseline in muscle strength Maximal isometric muscle strength in ankle plantarflexion and knee extension and flexion. within 1 weeks after intervention
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Not yet recruiting NCT02865174 - Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty Phase 4
Not yet recruiting NCT02826850 - Saphenous Nerve Radiofrequency for Knee Osteoarthritis Trial Phase 3
Completed NCT02881775 - Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis N/A